Berlin: Bei Partnern noch vor dem Fest lieferbar
Bookbot

Uday Jain

    Myocardial Ischemia and Infarction During Coronary Artery Bypass Surgery
    Clinical Effects and Management of COVID-19
    • 2021

      This book discusses organ damage due to COVID-19. Inflammation, endotheliitis, and coagulopathy lead to organ damage. Lungs, heart, kidneys, brain, eyes, gastrointestinal tract, skin, and mental status are adversely affected. The effect on the respiratory system is explored in detail. Utilization of personal protective equipment (PPE) to protect medical personnel and others is elaborated. The adverse effects of shortage of PPE are scrutinized. Limitations of airway barrier enclosures for reducing transmission between patients and medical personnel are considered. The therapeutics for COVID-19 approved in USA by the National Institutes of Health and/ or the Federal Drug Administration are reviewed. Remdesivir and some monoclonal antibody cocktails are recommended for early stage disease. Dexamethasone is recommended for severe disease.

      Clinical Effects and Management of COVID-19
    • 2021

      Perioperative myocardial ischemia and necrosis are substantially more common during coronary artery bypass surgery than appreciated until recently. They occur most commonly within hours after release of aortic occlusion. Coronary vasospasm after protamine administration contributes to their occurrence. This book describes in detail their causes, locations, and diagnosis, Perioperative ischemia and infarction are most commonly diagnosed by eloctrocardiography, echocardiography, and serum enzymes. Approaches to management are also discussed.

      Myocardial Ischemia and Infarction During Coronary Artery Bypass Surgery